The US Department of Health and Human Services (HHS) has warned that more than 32,000 of its staff could be furloughed if ...

US drugmaker AbbVie has announced plans to launch Elahere (mirvetuximab soravtansine-gynx) in the UK at a list price equal to ...

US biotech Star Therapeutics, which is developing best-in-class antibodies for bleeding disorders and other diseases, today ...

San Diego, USA-based biotech AnaptysBio saw its shares climb by 10.4% to $25.70 in pre-market trading, following its ...

Privately-held French biotech focused on providing immuno-therapeutics Biomunex Pharmaceuticals today announced a capital ...

Shares in Enanta Pharmaceuticals, a US biotech creating small molecule drugs for viral infections and immunological diseases, ...

US obesity firm Metsera has presented new data that demonstrates why pharma giant Pfizer is paying up to $7.3 billion to buy ...

Shares of US clinical-stage biotech Dogwood Therapeutics soared a massive 43% to $7.91 yesterday, on the news it has secured ...

US health technology body ICER will review the comparative clinical effectiveness and value of four COVID-19 vaccines: Pfizer ...

For years, rare diseases were seen as a safe harbor for biotech and pharma: small patient populations, little competition, ...

Japanese drugmaker Eisai and US biotech major Biogen have presented new clinical data from a post-hoc sub-group analysis of ...

US eye disease specialist Kala Bio saw its shares close down almost 90% at $2.04 yesterday, after it revealed disappointing ...